ACADIA Pharmaceuticals Inc (ACAD)

Add to Watchlists
Create an Alert
Quickflows
18.81 -0.97  -4.90% NASDAQ Nov 26, 12:59 18.80 -0.01  -0.05% After-Hours: 13:59 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All ACAD News

News

View All Events

Events

Date Type Description
02/24/2022 Earnings Results Q4 2021 Earnings Results
02/24/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
11/08/2021 Earnings Results Q3 2021 Earnings Results
11/08/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/22/2021 12:00 EST AGM 2020 Annual General Meeting
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 17:00 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 474.39M
Total Expenses (TTM) 667.34M
Net Income (TTM) -191.54M

Balance Sheet View Statement

Total Assets (Quarterly) 717.67M
Total Liabilities (Quarterly) 150.72M
Shareholders Equity (Quarterly) 566.96M

Cash Flow Statement View Statement

Cash from Operations (TTM) -130.03M
Cash from Investing (TTM) -259.61M
Cash from Financing (TTM) 31.92M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
  • URL: https://www.acadia-pharm.com
  • Investor Relations URL: https://ir.acadia-pharm.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 24, 2022
  • Last Earnings Release: Nov. 08, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 18.81
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
F000016ZD9 ST Healthcare Innovations 11 CA 4.19%
FBT First Trust NYSE Arca Biotech ETF 3.92%
SBIO ALPS Medical Breakthroughs ETF 1.96%
SMHCIX ST Healthcare Innovations 9 RE 1.79%
F000015MKJ FT Biotechnology 50 F CA 1.71%
F000014VC5 FT Biotechnology 48 CA 1.61%
FONBXX FT Biotechnology 47 RE 1.40%
FUVVKX FT Biotechnology 49 RE 1.30%
XBI SPDR® S&P Biotech ETF 0.99%
LABU Direxion Daily S&P Biotech Bull 3X ETF 0.75%

Comparables

Edit
FOLD Amicus Therapeutics Inc
UTHR United Therapeutics Corp
VNDA Vanda Pharmaceuticals Inc
EPZM Epizyme Inc
KPTI Karyopharm Therapeutics Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.